메뉴 건너뛰기




Volumn 121, Issue 19, 2015, Pages 3403-3411

Applying precision medicine to the active surveillance of prostate cancer

Author keywords

active surveillance; biomarker; gene expression; prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84941937042     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29496     Document Type: Review
Times cited : (18)

References (66)
  • 1
    • 84921755394 scopus 로고    scopus 로고
    • Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    • Klotz L, Vesprini D, Sethukavalan P, et al., Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015; 33: 272-277.
    • (2015) J Clin Oncol. , vol.33 , pp. 272-277
    • Klotz, L.1    Vesprini, D.2    Sethukavalan, P.3
  • 2
    • 84904268830 scopus 로고    scopus 로고
    • Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy
    • Bishoff JT, Freedland SJ, Gerber L, et al., Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy. J Urol. 2014; 192: 409-414.
    • (2014) J Urol. , vol.192 , pp. 409-414
    • Bishoff, J.T.1    Freedland, S.J.2    Gerber, L.3
  • 3
    • 84908360875 scopus 로고    scopus 로고
    • Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
    • Shipitsin M, Small C, Choudhury S, et al., Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error. Br J Cancer. 2014; 111: 1201-1212.
    • (2014) Br J Cancer. , vol.111 , pp. 1201-1212
    • Shipitsin, M.1    Small, C.2    Choudhury, S.3
  • 4
    • 84905922873 scopus 로고    scopus 로고
    • A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
    • Klein EA, Cooperberg MR, Magi-Galluzzi C, et al., A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014; 66: 550-560.
    • (2014) Eur Urol. , vol.66 , pp. 550-560
    • Klein, E.A.1    Cooperberg, M.R.2    Magi-Galluzzi, C.3
  • 5
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society. Available at:. Accessed April 28
    • American Cancer Society. Cancer Facts & Figures 2015. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/index. Accessed April 28, 2015.
    • (2015) Cancer Facts & Figures 2015
  • 6
    • 84914164108 scopus 로고    scopus 로고
    • Current clinical presentation and treatment of localized prostate cancer in the United States
    • Mahmood U, Levy LB, Nguyen PL, et al., Current clinical presentation and treatment of localized prostate cancer in the United States. J Urol. 2014; 192: 1650-1656.
    • (2014) J Urol. , vol.192 , pp. 1650-1656
    • Mahmood, U.1    Levy, L.B.2    Nguyen, P.L.3
  • 7
    • 84880002079 scopus 로고    scopus 로고
    • Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007
    • Li J, Djenaba JA, Soman A, Rim SH, Master VA,. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate Cancer. 2012; 2012: e691380.
    • (2012) Prostate Cancer. , vol.2012 , pp. e691380
    • Li, J.1    Djenaba, J.A.2    Soman, A.3    Rim, S.H.4    Master, V.A.5
  • 8
    • 84908118271 scopus 로고    scopus 로고
    • Prevention and early detection of prostate cancer
    • Cuzick J, Thorat MA, Andriole G, et al., Prevention and early detection of prostate cancer. Lancet Oncol. 2014; 15: e484-e492.
    • (2014) Lancet Oncol. , vol.15 , pp. e484-e492
    • Cuzick, J.1    Thorat, M.A.2    Andriole, G.3
  • 9
    • 84920869134 scopus 로고    scopus 로고
    • Screening for prostate cancer in the US? Reduce the harms and keep the benefit
    • De Carvalho TM, Heijnsdijk EA, de Koning HJ,. Screening for prostate cancer in the US? Reduce the harms and keep the benefit. Int J Cancer. 2015; 136: 1600-1607.
    • (2015) Int J Cancer. , vol.136 , pp. 1600-1607
    • De Carvalho, T.M.1    Heijnsdijk, E.A.2    De Koning, H.J.3
  • 10
    • 84863961968 scopus 로고    scopus 로고
    • Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement
    • US Preventive Services Task Force
    • Moyer VA,; US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-134.
    • (2012) Ann Intern Med. , vol.157 , pp. 120-134
    • Moyer, V.A.1
  • 11
    • 84901519024 scopus 로고    scopus 로고
    • Implications of the new AUA guidelines on prostate cancer detection in the U.S
    • Cooperberg MR,. Implications of the new AUA guidelines on prostate cancer detection in the U.S. Curr Urol Rep. 2014; 15: 420.
    • (2014) Curr Urol Rep. , vol.15 , pp. 420
    • Cooperberg, M.R.1
  • 12
    • 84856200634 scopus 로고    scopus 로고
    • Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up
    • Andriole GL, Crawford ED, Grubb RL, et al., Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012; 104: 125-132.
    • (2012) J Natl Cancer Inst. , vol.104 , pp. 125-132
    • Andriole, G.L.1    Crawford, E.D.2    Grubb, R.L.3
  • 13
    • 84858212484 scopus 로고    scopus 로고
    • Prostate-cancer mortality at 11 years of follow-up
    • Schroder FH, Hugosson J, Roobol MJ, et al., Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012; 366: 981-990.
    • (2012) N Engl J Med. , vol.366 , pp. 981-990
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 14
    • 85006511607 scopus 로고    scopus 로고
    • Expected population impacts of discontinued prostate-specific antigen screening
    • Gulati R, Tsodikov A, Etzioni R, et al., Expected population impacts of discontinued prostate-specific antigen screening. Cancer. 2014; 120: 3519-3526.
    • (2014) Cancer. , vol.120 , pp. 3519-3526
    • Gulati, R.1    Tsodikov, A.2    Etzioni, R.3
  • 15
    • 62049083633 scopus 로고    scopus 로고
    • Pathological outcomes of candidates for active surveillance of prostate cancer
    • discussion 1633-1634
    • Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR,. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009; 181: 1628-1633; discussion 1633-1634.
    • (2009) J Urol. , vol.181 , pp. 1628-1633
    • Conti, S.L.1    Dall'era, M.2    Fradet, V.3    Cowan, J.E.4    Simko, J.5    Carroll, P.R.6
  • 16
    • 84922635904 scopus 로고    scopus 로고
    • Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer
    • Wong LM, Ferrara S, Alibhai SM, et al., Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer. Prostate Cancer Prostatic Dis. 2015; 18: 69-74.
    • (2015) Prostate Cancer Prostatic Dis. , vol.18 , pp. 69-74
    • Wong, L.M.1    Ferrara, S.2    Alibhai, S.M.3
  • 17
    • 84904575160 scopus 로고    scopus 로고
    • Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis
    • Elshafei A, Kartha G, Li Y, et al., Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis. Prostate. 2014; 74: 1183-1188.
    • (2014) Prostate. , vol.74 , pp. 1183-1188
    • Elshafei, A.1    Kartha, G.2    Li, Y.3
  • 18
    • 84868563896 scopus 로고    scopus 로고
    • Active surveillance for prostate cancer: A systematic review of the literature
    • Dall'Era MA, Albertsen PC, Bangma C, et al., Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012; 62: 976-983.
    • (2012) Eur Urol. , vol.62 , pp. 976-983
    • Dall'era, M.A.1    Albertsen, P.C.2    Bangma, C.3
  • 19
    • 84885003130 scopus 로고    scopus 로고
    • Analytical validation of the Oncotype DX prostate cancer assay-a clinical RT-PCR assay optimized for prostate needle biopsies
    • Knezevic D, Goddard AD, Natraj N, et al., Analytical validation of the Oncotype DX prostate cancer assay-a clinical RT-PCR assay optimized for prostate needle biopsies. BMC Genomics. 2013; 14: 690.
    • (2013) BMC Genomics. , vol.14 , pp. 690
    • Knezevic, D.1    Goddard, A.D.2    Natraj, N.3
  • 20
    • 84929016549 scopus 로고    scopus 로고
    • A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate cancer
    • Cullen J, Rosner IL, Brand TC, et al., A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate cancer. Eur Urol. 2014; 66: 550-560.
    • (2014) Eur Urol. , vol.66 , pp. 550-560
    • Cullen, J.1    Rosner, I.L.2    Brand, T.C.3
  • 21
    • 84973610134 scopus 로고    scopus 로고
    • Clinical utility of a 17-gene genomic prostate score for treatment selection in men with newly diagnosed prostate cancer
    • (suppl; abstr e16124)
    • Dall'Era MA, Denes B, Lawrence HJ, et al., Clinical utility of a 17-gene genomic prostate score for treatment selection in men with newly diagnosed prostate cancer. J Clin Oncol. 2015; 33 (suppl; abstr e16124)
    • (2015) J Clin Oncol. , vol.33
    • Dall'era, M.A.1    Denes, B.2    Lawrence, H.J.3
  • 22
    • 84937631050 scopus 로고    scopus 로고
    • The impact of a biopsy based 17-gene genomic prostate score on treatment recommendations in men with newly diagnosed clinically prostate cancer who are candidates for active surveillance
    • Badani KK, Kemeter MJ, Febbo PG, et al., The impact of a biopsy based 17-gene genomic prostate score on treatment recommendations in men with newly diagnosed clinically prostate cancer who are candidates for active surveillance. Urol Pract. 2015; 2: 181-189.
    • (2015) Urol Pract , vol.2 , pp. 181-189
    • Badani, K.K.1    Kemeter, M.J.2    Febbo, P.G.3
  • 23
    • 79952042778 scopus 로고    scopus 로고
    • Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study
    • Cuzick J, Swanson GP, Fisher G, et al., Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 2011; 12: 245-255.
    • (2011) Lancet Oncol. , vol.12 , pp. 245-255
    • Cuzick, J.1    Swanson, G.P.2    Fisher, G.3
  • 24
    • 84862777506 scopus 로고    scopus 로고
    • Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
    • Cuzick J, Berney DM, Fisher G, et al., Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer. 2012; 106: 1095-1099.
    • (2012) Br J Cancer. , vol.106 , pp. 1095-1099
    • Cuzick, J.1    Berney, D.M.2    Fisher, G.3
  • 25
    • 84955690775 scopus 로고    scopus 로고
    • Prognostic value of the cell cycle progression score in patients with prostate cancer: A systematic review and meta-analysis
    • Sommariva S, Tarricone R, Lazzeri M, Ricciardi W, Montorsi F,. Prognostic value of the cell cycle progression score in patients with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2014 doi: 10.1016/j.eururo.2014.11.038.
    • (2014) Eur Urol.
    • Sommariva, S.1    Tarricone, R.2    Lazzeri, M.3    Ricciardi, W.4    Montorsi, F.5
  • 26
    • 84876080452 scopus 로고    scopus 로고
    • Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort
    • Cooperberg MR, Simko JP, Cowan JE, et al., Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013; 31: 1428-1434.
    • (2013) J Clin Oncol. , vol.31 , pp. 1428-1434
    • Cooperberg, M.R.1    Simko, J.P.2    Cowan, J.E.3
  • 27
    • 84900809745 scopus 로고    scopus 로고
    • Cell cycle progression score and treatment decisions in prostate cancer: Results from an ongoing registry
    • Crawford ED, Scholz MC, Kar AJ, et al., Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry. Curr Med Res Opin. 2014; 30: 1025-1031.
    • (2014) Curr Med Res Opin. , vol.30 , pp. 1025-1031
    • Crawford, E.D.1    Scholz, M.C.2    Kar, A.J.3
  • 28
    • 84896443096 scopus 로고    scopus 로고
    • Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer
    • Shore N, Concepcion R, Saltzstein D, et al., Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer. Curr Med Res Opin. 2014; 30: 547-553.
    • (2014) Curr Med Res Opin. , vol.30 , pp. 547-553
    • Shore, N.1    Concepcion, R.2    Saltzstein, D.3
  • 29
    • 84941947994 scopus 로고    scopus 로고
    • Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer
    • [published online ahead of print March 2, ]
    • Blume-Jensen P, Berman DM, Rimm DL, et al., Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer [published online ahead of print March 2, 2015 ]. Clin Cancer Res.
    • (2015) Clin Cancer Res.
    • Blume-Jensen, P.1    Berman, D.M.2    Rimm, D.L.3
  • 30
    • 84921730987 scopus 로고    scopus 로고
    • Long-term active surveillance for prostate cancer: Answers and questions
    • Cooperberg MR,. Long-term active surveillance for prostate cancer: answers and questions. J Clin Oncol. 2015; 33: 238-240.
    • (2015) J Clin Oncol. , vol.33 , pp. 238-240
    • Cooperberg, M.R.1
  • 31
    • 84941943823 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network. Accessed January 28
    • National Comprehensive Cancer Network. NCCN Guidelines Version 1.2015 Prostate Cancer. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed January 28, 2015.
    • (2015) NCCN Guidelines Version 1.2015 Prostate Cancer
  • 32
    • 62049086309 scopus 로고    scopus 로고
    • A multi-institutional evaluation of active surveillance for low risk prostate cancer
    • Eggener SE, Mueller A, Berglund RK, et al., A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol. 2009; 181: 1635-1641.
    • (2009) J Urol. , vol.181 , pp. 1635-1641
    • Eggener, S.E.1    Mueller, A.2    Berglund, R.K.3
  • 33
    • 84880699871 scopus 로고    scopus 로고
    • Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer
    • King AC, Livermore A, Laurila TA, Huang W, Jarrad DF,. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer. Urol Oncol. 2013; 31: 739-743.
    • (2013) Urol Oncol. , vol.31 , pp. 739-743
    • King, A.C.1    Livermore, A.2    Laurila, T.A.3    Huang, W.4    Jarrad, D.F.5
  • 34
    • 84895473498 scopus 로고    scopus 로고
    • Radical prostatectomy or watchful waiting in early prostate cancer
    • Bill-Axelson A, Holmberg L, Garmo H, et al., Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370: 932-942.
    • (2014) N Engl J Med. , vol.370 , pp. 932-942
    • Bill-Axelson, A.1    Holmberg, L.2    Garmo, H.3
  • 35
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • Wilt TJ, Brawer MK, Jones KM, et al., Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012; 367: 203-213.
    • (2012) N Engl J Med. , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 36
    • 77749286517 scopus 로고    scopus 로고
    • Short-term outcomes of the prospective multicentre "prostate Cancer Research International: Active Surveillance" study
    • Van den Bergh RC, Vasarainen H, van der Poel HG, et al., Short-term outcomes of the prospective multicentre "Prostate Cancer Research International: Active Surveillance" study. BJU Int. 2010; 105: 956-962.
    • (2010) BJU Int. , vol.105 , pp. 956-962
    • Van Den Bergh, R.C.1    Vasarainen, H.2    Van Der Poel, H.G.3
  • 37
    • 84874546786 scopus 로고    scopus 로고
    • Active surveillance for low-risk prostate cancer worldwide: The PRIAS study
    • Bul M, Zhu X, Valdagni R, et al., Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol. 2013; 63: 597-603.
    • (2013) Eur Urol. , vol.63 , pp. 597-603
    • Bul, M.1    Zhu, X.2    Valdagni, R.3
  • 38
    • 84893851086 scopus 로고    scopus 로고
    • The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance
    • Ehdaie B, Vertosick E, Spaliviero M, et al., The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol. 2014; 191: 660-664.
    • (2014) J Urol. , vol.191 , pp. 660-664
    • Ehdaie, B.1    Vertosick, E.2    Spaliviero, M.3
  • 39
    • 80053983328 scopus 로고    scopus 로고
    • Complications after prostate biopsy: Data from SEER-Medicare
    • Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM,. Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011; 186: 1830-1834.
    • (2011) J Urol. , vol.186 , pp. 1830-1834
    • Loeb, S.1    Carter, H.B.2    Berndt, S.I.3    Ricker, W.4    Schaeffer, E.M.5
  • 40
    • 84903466463 scopus 로고    scopus 로고
    • Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence
    • Long Q, Xu J, Osunkoya AO, et al., Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res. 2014; 74: 3228-3237.
    • (2014) Cancer Res. , vol.74 , pp. 3228-3237
    • Long, Q.1    Xu, J.2    Osunkoya, A.O.3
  • 41
    • 84907819350 scopus 로고    scopus 로고
    • Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells
    • Peng Z, Andersson K, Lindholm J, et al., Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells. PLoS One. 2014; 9: e109610.
    • (2014) PLoS One. , vol.9 , pp. e109610
    • Peng, Z.1    Andersson, K.2    Lindholm, J.3
  • 42
    • 84883119308 scopus 로고    scopus 로고
    • Overdiagnosis and overtreatment in cancer: An opportunity for improvement
    • Esserman LJ, Thompson IM Jr, Reid B,. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310: 797-798.
    • (2013) JAMA. , vol.310 , pp. 797-798
    • Esserman, L.J.1    Thompson, I.M.2    Reid, B.3
  • 43
    • 84864866294 scopus 로고    scopus 로고
    • Frequency and determinants of disagreement and error in Gleason scores: A population-based study of prostate cancer
    • Goodman M, Ward KC, Osunkoya AO, et al., Frequency and determinants of disagreement and error in Gleason scores: a population-based study of prostate cancer. Prostate. 2012; 72: 1389-1398.
    • (2012) Prostate. , vol.72 , pp. 1389-1398
    • Goodman, M.1    Ward, K.C.2    Osunkoya, A.O.3
  • 44
    • 84902343091 scopus 로고    scopus 로고
    • Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists
    • Berney DM, Algaba F, Camparo P, et al., Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. Virchows Arch. 2014; 464: 583-587.
    • (2014) Virchows Arch. , vol.464 , pp. 583-587
    • Berney, D.M.1    Algaba, F.2    Camparo, P.3
  • 45
    • 79960182780 scopus 로고    scopus 로고
    • The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: A multi-institutional study
    • McKenney JK, Simko J, Bonham M, et al., The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol. 2011; 186: 465-469.
    • (2011) J Urol. , vol.186 , pp. 465-469
    • McKenney, J.K.1    Simko, J.2    Bonham, M.3
  • 46
    • 0035126050 scopus 로고    scopus 로고
    • Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists
    • Allsbrook WC Jr, Mangold KA, Johnson MH, et al., Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol. 2001; 32: 74-80.
    • (2001) Hum Pathol. , vol.32 , pp. 74-80
    • Allsbrook, W.C.1    Mangold, K.A.2    Johnson, M.H.3
  • 47
    • 84908356936 scopus 로고    scopus 로고
    • Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance
    • Weiner AB, Etzioni R, Eggener SE,. Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance. Eur Urol. 2014; 66: 611-612.
    • (2014) Eur Urol. , vol.66 , pp. 611-612
    • Weiner, A.B.1    Etzioni, R.2    Eggener, S.E.3
  • 48
    • 84921480826 scopus 로고    scopus 로고
    • Gleason inflation 1998-2011: A registry study of 97,168 men
    • Danneman D, Drevin L, Robinson D, Stattin P, Egevad L,. Gleason inflation 1998-2011: a registry study of 97,168 men. BJU Int. 2015; 115: 248-255.
    • (2015) BJU Int. , vol.115 , pp. 248-255
    • Danneman, D.1    Drevin, L.2    Robinson, D.3    Stattin, P.4    Egevad, L.5
  • 49
    • 24144493035 scopus 로고    scopus 로고
    • The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    • ISUP Grading Committee
    • Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL,; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29: 1228-1242.
    • (2005) Am J Surg Pathol. , vol.29 , pp. 1228-1242
    • Epstein, J.I.1    Allsbrook, W.C.2    Amin, M.B.3    Egevad, L.L.4
  • 50
    • 84925750882 scopus 로고    scopus 로고
    • Repeated biopsies in patients with prostate cancer on active surveillance: Clinical implications of interobserver variation in histopathological assessment
    • Thomsen FB, Marcussen N, Berg KD, et al., Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessment. BJU Int. 2015; 115: 599-605.
    • (2015) BJU Int. , vol.115 , pp. 599-605
    • Thomsen, F.B.1    Marcussen, N.2    Berg, K.D.3
  • 51
    • 84921475666 scopus 로고    scopus 로고
    • Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer
    • Abdi H, Pourmalek F, Zargar H, et al., Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer. Urology. 2015; 85: 423-429.
    • (2015) Urology. , vol.85 , pp. 423-429
    • Abdi, H.1    Pourmalek, F.2    Zargar, H.3
  • 52
    • 84877722087 scopus 로고    scopus 로고
    • Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance
    • Mullins JK, Bonekamp D, Landis P, et al., Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int. 2013; 111: 1037-1045.
    • (2013) BJU Int. , vol.111 , pp. 1037-1045
    • Mullins, J.K.1    Bonekamp, D.2    Landis, P.3
  • 53
    • 84923104615 scopus 로고    scopus 로고
    • Magnetic resonance imaging in active surveillance of prostate cancer: A systematic review
    • Schoots IG, Petrides N, Giganti F, et al., Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol. 2015; 67: 627-636.
    • (2015) Eur Urol. , vol.67 , pp. 627-636
    • Schoots, I.G.1    Petrides, N.2    Giganti, F.3
  • 54
    • 84919400569 scopus 로고    scopus 로고
    • Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: A preliminary report on disease outcomes
    • Dianat SS, Carter HB, Pienta KJ, et al., Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes. Urology. 2015; 85: 147-154.
    • (2015) Urology. , vol.85 , pp. 147-154
    • Dianat, S.S.1    Carter, H.B.2    Pienta, K.J.3
  • 55
    • 84983156848 scopus 로고    scopus 로고
    • Defining the learning curve for multi-parametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool
    • [published online ahead of print August 7, ]. doi: 10.1111/bju.12892
    • Gaziev G, Wadhwa K, Barrett T, et al., Defining the learning curve for multi-parametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool [published online ahead of print August 7, 2014 ]. BJU Int. doi: 10.1111/bju.12892.
    • (2014) BJU Int.
    • Gaziev, G.1    Wadhwa, K.2    Barrett, T.3
  • 56
    • 84902997681 scopus 로고    scopus 로고
    • Prognostic value of a cell-cycle progression score in men with prostate cancer managed with active surveillance after MRI-guided prostate biopsy-a pilot study
    • Arsov C, Jankowiak F, Hiester A, et al., Prognostic value of a cell-cycle progression score in men with prostate cancer managed with active surveillance after MRI-guided prostate biopsy-a pilot study. Anticancer Res. 2014; 34: 2459-2466.
    • (2014) Anticancer Res. , vol.34 , pp. 2459-2466
    • Arsov, C.1    Jankowiak, F.2    Hiester, A.3
  • 57
    • 84922277700 scopus 로고    scopus 로고
    • Active surveillance of prostate cancer in African American men
    • Silberstein JL, Feibus AH, Maddox MM, et al., Active surveillance of prostate cancer in African American men. Urology. 2014; 84: 1255-1261.
    • (2014) Urology. , vol.84 , pp. 1255-1261
    • Silberstein, J.L.1    Feibus, A.H.2    Maddox, M.M.3
  • 58
    • 84922286332 scopus 로고    scopus 로고
    • Racial disparities in oncologic outcomes after radical prostatectomy: Long-term follow-up
    • Faisal FA, Sundi D, Cooper JL, et al., Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. Urology. 2014; 84: 1434-1441.
    • (2014) Urology. , vol.84 , pp. 1434-1441
    • Faisal, F.A.1    Sundi, D.2    Cooper, J.L.3
  • 59
    • 84886860803 scopus 로고    scopus 로고
    • African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: Should active surveillance still be an option for them?
    • Sundi D, Ross AE, Humphreys EB, et al., African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol. 2013; 31: 2991-2997.
    • (2013) J Clin Oncol. , vol.31 , pp. 2991-2997
    • Sundi, D.1    Ross, A.E.2    Humphreys, E.B.3
  • 60
    • 84875539458 scopus 로고    scopus 로고
    • Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance
    • Ha YS, Salmasi A, Karellas M, et al., Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology. 2013; 81: 831-835.
    • (2013) Urology. , vol.81 , pp. 831-835
    • Ha, Y.S.1    Salmasi, A.2    Karellas, M.3
  • 61
    • 84890115543 scopus 로고    scopus 로고
    • Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men
    • Sundi D, Kryvenko ON, Carter HB, Ross AE, Epstein JI, Schaeffer EM,. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol. 2014; 191: 60-67.
    • (2014) J Urol. , vol.191 , pp. 60-67
    • Sundi, D.1    Kryvenko, O.N.2    Carter, H.B.3    Ross, A.E.4    Epstein, J.I.5    Schaeffer, E.M.6
  • 62
    • 84922219179 scopus 로고    scopus 로고
    • Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics
    • Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR,. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol. 2015; 67: 451-457.
    • (2015) Eur Urol. , vol.67 , pp. 451-457
    • Jalloh, M.1    Myers, F.2    Cowan, J.E.3    Carroll, P.R.4    Cooperberg, M.R.5
  • 63
    • 84893361104 scopus 로고    scopus 로고
    • Active surveillance for African-American men with prostate cancer: Of course! Pro
    • 84-85
    • Moul JW,. Active surveillance for African-American men with prostate cancer: of course! Pro. Oncology (Williston Park). 2014; 28: 82, 84-85.
    • (2014) Oncology (Williston Park). , vol.28 , pp. 82
    • Moul, J.W.1
  • 64
    • 84899478777 scopus 로고    scopus 로고
    • Active surveillance for African-American men with prostate cancer: Proceed with caution. Con
    • Sundi D, Schaeffer EM,. Active surveillance for African-American men with prostate cancer: proceed with caution. Con. Oncology (Williston Park). 2014; 28: 83, 85.
    • (2014) Oncology (Williston Park). , vol.28 , pp. 83-85
    • Sundi, D.1    Schaeffer, E.M.2
  • 65
    • 84880042774 scopus 로고    scopus 로고
    • Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy
    • Freedland SJ, Gerber L, Reid J, et al., Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 86: 848-853.
    • (2013) Int J Radiat Oncol Biol Phys. , vol.86 , pp. 848-853
    • Freedland, S.J.1    Gerber, L.2    Reid, J.3
  • 66
    • 84862832081 scopus 로고    scopus 로고
    • Active surveillance versus surgery for low risk prostate cancer: A clinical decision analysis
    • Liu D, Lehmann HP, Frick KD, Carter HB,. Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis. J Urol. 2012; 187: 1241-1246.
    • (2012) J Urol. , vol.187 , pp. 1241-1246
    • Liu, D.1    Lehmann, H.P.2    Frick, K.D.3    Carter, H.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.